Sun Pharma gets DCGI nod to market generic semaglutide injection
Published on: Jan. 23, 2026, 3:08 p.m. | Source: Daily Excelsior
New Delhi, Jan 23 : Sun Pharmaceutical Industries on Friday said it has received approval from the national drug regulator to sell a generic version of semaglutide injection for chronic weight management. The company has received approval from the Drugs Controller General of India (DCGI) to manufacture and market Semaglutide injection, a glucagon-like peptide-1 (GLP-1) receptor agonist indicated for chronic weight management in adults as an adjunct to a reduced-calorie diet and increased physical activity. The company will launch the […]
